Waylivra
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Waylivra, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: EMA Authorised: Waylivra (volanesorsen sodium) — Akcea Therapeutics Ireland Limited